IP Library Granted Patent US 7,468,427
Granted Patent B2
US 7,468,427 · App. 11/341,175 · Granted Dec 23, 2008

Antibodies to PRO1275 polypeptide

Assignee: Genentech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,468,427
App. No.
11/341,175
Granted
Dec 23, 2008
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (16)

1. An isolated antibody which specifically binds to the polypeptide of SEQ ID NO:2.

2. The antibody of claim 1 , wherein said antibody is a monoclonal antibody.

3. The antibody of claim 1 , wherein the antibody is an antibody fragment.

4. The antibody of claim 3 , wherein the antibody fragment is a Fab, Fab′, F(ab′) 2 , or Fv fragment.

5. The antibody of claim 3 , wherein the antibody fragment is a single-chain antibody.

6. The antibody of claim 1 , wherein the antibody is a humanized antibody.

7. The antibody of claim 1 , wherein the antibody is a human antibody.

8. A composition comprising the antibody of claim 3 conjugated to a label.

9. The antibody of claim 1 , wherein the antibody binds to amino acids 26-119 of SEQ ID NO:2.

10. The antibody of claim 9 , wherein the antibody is a monoclonal antibody.

11. The antibody of claim 9 , wherein the antibody is an antibody fragment.

12. The antibody of claim 11 , wherein the antibody fragment is a Fab, Fab′, F(ab′) 2 , or Fv fragment.

13. The antibody of claim 11 , wherein the antibody fragment is a single-chain antibody.

14. The antibody of claim 9 , wherein the antibody is a humanized antibody.

15. The antibody of claim 9 , wherein the antibody is a human antibody.

16. A composition comprising the antibody of claim 9 conjugated to a label.

Continuity (7)
Continuation 1012784100 · Apr 22, 2002
Continuation 1002807200 · Dec 19, 2001
Continuation PCTUS003267800 · Dec 1, 2000
Continuation In Part PCTUS000434200 · Feb 18, 2000
Continuation In Part 0940329700
Provisional Application 6009953600 · Sep 9, 1998
Related Publication 20060194283A1 · Aug 31, 2006